Andrew M Scott

Estimating the impact of treatment and imaging modalities on 5-year net survival of 11 cancers in 200 countries: a simulation-based analysis.

H. Hricak, H. Vargas, R. Atun, 2020, The Lancet. Oncology.

Guardians of precision: advancing radiation protection, safety, and quality systems in nuclear medicine

Miriam Mikhail-Lette, Enrique Estrada Lobato, Francesco Giammarile, 2024, European journal of nuclear medicine and molecular imaging.

Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial.

T. Tan, E. Kwan, S. Ramdave, 2023, The Lancet. Oncology.